Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, et al. Nat Med 2025 Jan 20. doi: 10.1038/s41591-024-03478.

Read + Share

Amedeo Smart

Independent Medical Education

Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, et al. Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies. Nat Med 2025 Jan 20. doi: 10.1038/s41591-024-03478.
PMID: 39833408